<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/"><channel><title>同写意 | wechat-feeds</title><link>http://MzA4MzgzMDM5Mg.favicon.privacyhide.com/favicon.ico</link><description>一个以新药创制为核心，汇集国内一流研发精英的大型交流与价值分享平台。“同筑技术人生路，写意中国新药魂”是同写意的初衷与愿景。秉承汇集“一线、一流”，讲求“实用、实在、时效”的原则。</description><managingEditor> (hellodword)</managingEditor><pubDate>Wed, 21 Apr 2021 07:21:48 +0800</pubDate><image><url>http://MzA4MzgzMDM5Mg.favicon.privacyhide.com/favicon.ico</url><title>同写意 | wechat-feeds</title><link>http://MzA4MzgzMDM5Mg.favicon.privacyhide.com/favicon.ico</link><width>64</width><height>64</height></image><item><title>百奥赛图（南通）新药创制基地启动暨百奥动物（BioMice）品牌发布会</title><link>https://mp.weixin.qq.com/s/tXYj9zZILpQCLaa5oX1thA</link><description></description><content:encoded><![CDATA[百奥赛图（南通）新药创制基地启动暨百奥动物（BioMice）品牌发布会]]></content:encoded><pubDate>Tue, 20 Apr 2021 23:57:47 +0800</pubDate></item><item><title>​方达医药收购Ocean Ridge Biosciences，扩展基因组学服务</title><link>https://mp.weixin.qq.com/s/p9Y_GszTAHEI4kcY2BoQhA</link><description></description><content:encoded><![CDATA[​方达医药收购Ocean Ridge Biosciences，扩展基因组学服务]]></content:encoded><pubDate>Tue, 20 Apr 2021 23:57:47 +0800</pubDate></item><item><title>荣昌生物自主研发，国内首款ADC药预计6月获批</title><link>https://mp.weixin.qq.com/s/FagydjlMzTBBkBFaXe6iUw</link><description></description><content:encoded><![CDATA[荣昌生物自主研发，国内首款ADC药预计6月获批]]></content:encoded><pubDate>Tue, 20 Apr 2021 23:57:47 +0800</pubDate></item><item><title>写意云课丨第68期：液体硬胶囊——水溶性差和高效能药物的胶囊型解决方案</title><link>https://mp.weixin.qq.com/s/9ACql3yI_wazO8zAtlF79w</link><description></description><content:encoded><![CDATA[写意云课丨第68期：液体硬胶囊——水溶性差和高效能药物的胶囊型解决方案]]></content:encoded><pubDate>Tue, 20 Apr 2021 23:57:47 +0800</pubDate></item><item><title>倒计时3天丨160+大咖齐聚太湖湾，赴一场思想激荡盛宴</title><link>https://mp.weixin.qq.com/s/I5Lr3Z64ACwGHBpHLtUksg</link><description></description><content:encoded><![CDATA[倒计时3天丨160+大咖齐聚太湖湾，赴一场思想激荡盛宴]]></content:encoded><pubDate>Mon, 19 Apr 2021 22:57:38 +0800</pubDate></item><item><title>终日乾乾，与时偕行—老牌德企CMO的中国历程</title><link>https://mp.weixin.qq.com/s/MFROcgGdZZT74-0P8nHA3w</link><description></description><content:encoded><![CDATA[终日乾乾，与时偕行—老牌德企CMO的中国历程]]></content:encoded><pubDate>Mon, 19 Apr 2021 22:57:38 +0800</pubDate></item><item><title>FDA孤儿药认定——新药研发与审评的加速通道</title><link>https://mp.weixin.qq.com/s/vS83-QRgVsaKHGCfI2rnsg</link><description></description><content:encoded><![CDATA[FDA孤儿药认定——新药研发与审评的加速通道]]></content:encoded><pubDate>Mon, 19 Apr 2021 22:57:38 +0800</pubDate></item><item><title>陈怡：创新药全生命周期的准入管理在新环境下的思考和策略</title><link>https://mp.weixin.qq.com/s/nALK7s4BcwbGcWeDiRk02w</link><description></description><content:encoded><![CDATA[陈怡：创新药全生命周期的准入管理在新环境下的思考和策略]]></content:encoded><pubDate>Sun, 18 Apr 2021 23:42:36 +0800</pubDate></item><item><title>烟花三月下扬州，80余位总裁相约4月扬州生物医药论坛（NEW）</title><link>https://mp.weixin.qq.com/s/nQG3NdpIHtausWKvWP5ODg</link><description></description><content:encoded><![CDATA[烟花三月下扬州，80余位总裁相约4月扬州生物医药论坛（NEW）]]></content:encoded><pubDate>Sun, 18 Apr 2021 23:42:36 +0800</pubDate></item><item><title>疫苗龙头遭遇暴击，投资大逻辑迎来毁灭性崩坏？</title><link>https://mp.weixin.qq.com/s/PT9JMcUIQxWF-tdxZs-jJA</link><description></description><content:encoded><![CDATA[疫苗龙头遭遇暴击，投资大逻辑迎来毁灭性崩坏？]]></content:encoded><pubDate>Sun, 18 Apr 2021 23:42:36 +0800</pubDate></item><item><title>写意报告丨PD-1/PD-L1相关药物发明的专利保护</title><link>https://mp.weixin.qq.com/s/AF5t7HQUD2bKIwcK4VJVSQ</link><description></description><content:encoded><![CDATA[写意报告丨PD-1/PD-L1相关药物发明的专利保护]]></content:encoded><pubDate>Sat, 17 Apr 2021 19:42:46 +0800</pubDate></item><item><title>博腾生物完成A轮融资，加速布局基因与细胞治疗CDMO商业化生产</title><link>https://mp.weixin.qq.com/s/vG_mv1pEXptUjSVPDs6ETw</link><description></description><content:encoded><![CDATA[博腾生物完成A轮融资，加速布局基因与细胞治疗CDMO商业化生产]]></content:encoded><pubDate>Sat, 17 Apr 2021 19:42:46 +0800</pubDate></item><item><title>关注杜丨胃癌治疗新突破，首款联合免疫疗法获FDA批准</title><link>https://mp.weixin.qq.com/s/NRzuoX_xYpD1fHJDYEQ3Mw</link><description></description><content:encoded><![CDATA[关注杜丨胃癌治疗新突破，首款联合免疫疗法获FDA批准]]></content:encoded><pubDate>Sat, 17 Apr 2021 19:42:46 +0800</pubDate></item><item><title>论持久战：Theseus肿瘤全程用药战略</title><link>https://mp.weixin.qq.com/s/MtR7BXm6oVEO5DNFymYo-A</link><description></description><content:encoded><![CDATA[论持久战：Theseus肿瘤全程用药战略]]></content:encoded><pubDate>Sat, 17 Apr 2021 19:42:46 +0800</pubDate></item><item><title>写意报告︱董增军：打造生物医药创新创业生态圈</title><link>https://mp.weixin.qq.com/s/erUaUnGJjuxsyr3VJx8fAg</link><description></description><content:encoded><![CDATA[写意报告︱董增军：打造生物医药创新创业生态圈]]></content:encoded><pubDate>Fri, 16 Apr 2021 19:05:01 +0800</pubDate></item><item><title>开拓药业福瑞他恩治疗痤疮I/II期临床试验完成首批受试者给药</title><link>https://mp.weixin.qq.com/s/NmlEtHyZzNT_UXpn2TA4HA</link><description></description><content:encoded><![CDATA[开拓药业福瑞他恩治疗痤疮I/II期临床试验完成首批受试者给药]]></content:encoded><pubDate>Fri, 16 Apr 2021 19:05:01 +0800</pubDate></item><item><title>2021太湖湾生命健康未来大会丨创新医药和智慧医疗会议</title><link>https://mp.weixin.qq.com/s/US4WIXpvU4Wc7YrYn39mhg</link><description></description><content:encoded><![CDATA[2021太湖湾生命健康未来大会丨创新医药和智慧医疗会议]]></content:encoded><pubDate>Fri, 16 Apr 2021 19:05:01 +0800</pubDate></item><item><title>药物制剂元素杂质控制该如何做？</title><link>https://mp.weixin.qq.com/s/6bevzjG1QFNqzi4uIXVh_Q</link><description></description><content:encoded><![CDATA[药物制剂元素杂质控制该如何做？]]></content:encoded><pubDate>Fri, 16 Apr 2021 19:05:01 +0800</pubDate></item><item><title>AACR：细胞因子新时代</title><link>https://mp.weixin.qq.com/s/OkSNdQvDL4uwVEaUtMPTJg</link><description></description><content:encoded><![CDATA[AACR：细胞因子新时代]]></content:encoded><pubDate>Fri, 16 Apr 2021 19:05:01 +0800</pubDate></item><item><title>CRO并购与全球化之路如何走？</title><link>https://mp.weixin.qq.com/s/nqTUu9KzJWvZNfzuwKLGQw</link><description></description><content:encoded><![CDATA[CRO并购与全球化之路如何走？]]></content:encoded><pubDate>Thu, 15 Apr 2021 21:21:29 +0800</pubDate></item></channel></rss>